Originalkatalog | Verfügbarkeit prüfen

Therapeutic Drug Monitoring of Oral Anticancer Drugs:The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study

Groenland, Stefanie L., van Eerden, Ruben A. G., Verheijen, Remy B., Koolen, Stijn L. W., Moes, Dirk Jan A. R., Desar, Ingrid M. E., Reyners, Anna K. L., Gelderblom, Hans J., van Erp, Nielka P., Mathijssen, Ron H. J., Huitema, Alwin D. R., Steeghs, Neeltje
Veröffentlicht in: Dutch Pharmacology Oncology Grp , Groenland , S L , van Eerden , R A G , Verheijen , R B , Koolen , S L W , Moes , D J A R , Desar , I M E , Reyners , A K L , Gelderblom , H J , van Erp , N P , Mathijssen , R H J , Huitema , A D R & Steeghs , N 2019 , ' Therapeutic Drug Monitoring of Oral Anticancer Drugs : The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study ' , Therapeutic Drug Monitoring , vol. 41 , no. 5 , pp. 561-567 . https://doi.org/10.1097/FTD.0000000000000654;
2019

Originalkatalog | Verfügbarkeit prüfen

A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir

de Weger, Vincent A, Stuurman, Frederik E, Hendrikx, Jeroen J M A, Moes, Johannes J, Sawicki, Emilia, Huitema, Alwin D R, Nuijen, Bastiaan, Thijssen, Bas, Rosing, Hilde, Keessen, Marianne, Mergui-Roelvink, Marja, Beijnen, Jos H, Schellens, Jan H M, Marchetti, Serena
2017

Originalkatalog | Verfügbarkeit prüfen

A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab

Hummel, Matthew, Bosje, Tjerk, Shaw, Andrew, Liu, Mark Shiyao, Barve, Abhijit, Kothekar, Mudgal, Socinski, Mark A., Waller, Cornelius
2021